Reagents & Assay Kits Is Expected To Remain The Largest Segment In The Global High Throughput Screening (hts) Market

By Author: Lucintel LLC
Total Articles: 7501
Comment this article

According to the recent study the High Throughput Screening (HTS) Market is projected to grow at a CAGR of 7%-9% from 2020 to 2025. Growth in this market is primarily driven by growing adoption of open innovation models in pharmaceutical and biotechnology companies, increasing R&D spending, and the availability of government funding and venture capital investments.
Browse XX figures / charts and XX tables in this 150 -page report to understand trends, opportunities and forecast in high throughput screening (HTS) market by product & service (reagents & assay kits, instruments, consumables & accessories, software, and services), technology (cell-based assays (2D cell culture, 3D cell culture (scaffold-based technology and scaffold-free technology), perfusion cell culture, and reporter based assays), lab-on-a-chip, ultra-high-throughput screening, bioinformatics, and label-free technology), application (drug discovery (target identification and validation, primary and secondary screening, and toxicology assessment), chemical biology programs, cell- & organ-based screening, biochemical screening, biological ...
... active compound screening, genomics, proteomics, and compound profiling), detection method (mass spectrometry (MS), chromatography, calorimetry, x-ray diffraction, and other detection methods), end user (pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CRO), and other end users) and region (North America, Europe, Asia Pacific, and Rest of the World).
Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/high-throughput-screening-market.aspx

“Reagents & assay kits market is expected to remain the largest segment during the forecast period.”
Based on product & service, the high throughput screening (HTS) market is segmented into reagents & assay kits, instruments, consumables & accessories, software, and services. Lucintel forecasts that the reagents & assay kits market is expected to remain the largest segment due to primarily be attributed to factors, such as the large number of reagents and assay kits used in HTS techniques, rising prevalence of a number of diseases, increasing pharmaceutical R&D, and increased government funding for life science research.
“Within the high throughput screening (HTS) market, the pharmaceutical & bioend user companies segment is expected to remain the largest end user.”
Based on end user the pharmaceutical & bioend user companies segment is expected to witness the highest growth over the forecast period due to primarily driven by the extensive use of the HTS technology in pharmaceutical and biotechnology companies for drug discovery applications along with increasing pharmaceutical R&D expenditure.
“North America will dominate the high throughput screening (HTS) market in near future.”
North America will remain the largest region over the forecast period due to large spending on pharmaceutical R&D, the growing adoption of HTS, and availability of government funding in this region.
Download Brochure of this report by clicking on https://www.lucintel.com/high-throughput-screening-market.aspx
Major players of high throughput screening (HTS) market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Agilent Technologies, Danaher, Thermofisher Scientific, PerkinElmer, Tecan Group, Merck Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam, and Aurora Biomed are among the major high throughput screening (HTS) providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/high-throughput-screening-market.aspx or helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Healthcare IT Market:
For more details click here https://www.lucintel.com/healthcare-it-market.aspx

Medical Holography Market:
For more details click here https://www.lucintel.com/medical-holography-market.aspx

Minimally Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

Endoscopy Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx

Industrial Microbiology Market:
For more details click here https://www.lucintel.com/opportunities-in-the-industrial-microbiologycolonopt-size,-trends-and-growth-analysis.aspx

Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx